Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

R&D In Brief

This article was originally published in The Tan Sheet

Executive Summary

Selenium/prostate cancer: Low serum levels of selenium lead to four- to five-fold increase in prostate cancer risk, Stanford, Johns Hopkins and National Institute on Aging researchers report in Dec. 1 Journal of Urology. Group measured plasma selenium in blood samples of 52 male prostate cancer patients donated prior to diagnosis; levels also were tested in 96 control subjects of comparable age. A multi-center study is underway to determine if increase in selenium intake elevates trace mineral's plasma levels, thereby decreasing cancer rate...
Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS093347

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel